Assessment of COVID-19 Associated Coagulopathy and Hypercoagulable State in Upper Egypt
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Coagulopathy
- Sponsor
- Assiut University
- Enrollment
- 106
- Locations
- 1
- Primary Endpoint
- Thrombophilia screen
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Coagulopathy is one of the most significant prognostic factors in patients with COVID-19 and is associated with increased mortality and admission to critical care. Most commonly observed coagulopathy in patients hospitalized with COVID-19 (COVID-19-associated coagulopathy) is characterized by increased D-dimer and fibrinogen levels. 71% of patients who did not survive hospitalization reported to have developed disseminated intravascular coagulation (DIC) compared to 0.6% of survivors.
Detailed Description
studying the detailed coagulation screen and second line coagulation parameters including both thrombophilia screen and other acute phase coagulation factors.
Investigators
Azza Abdelaal
lecturer of clinical pathology
Assiut University
Eligibility Criteria
Inclusion Criteria
- •patients with COVID 19 positive by RT- PCR
Exclusion Criteria
- •no exclusions
Outcomes
Primary Outcomes
Thrombophilia screen
Time Frame: 1 month
Full thrombophilia screen
VWF, FVIII
Time Frame: 1 month
VWFAg, FVIII
Coagulation screen
Time Frame: 1 month
Full coagulation screen